GWP.L Share News (GWP)

23 Apr 2012

GW Pharmaceuticals, the developer of cannabis-based medicinal products, has released a puff piece about a favourable review of its Sativex product in ...

2 Apr 2012

Rajan Tandon, a Non-Executive Director of FTSE 250 African energy firm Ophir, has ditched 10m shares in the firm, cashing in on the recent surge in it...

5 Jul 2011

Elementis traces its roots to 1844 and the Harrisons & Crosfield tea and coffee trading conglomerate, but it took its present shape in 1998, when the ...

17 May 2011

GW Pharmaceuticals, the developer of cannabis-based medicinal products, moved into the black at the interim stage on the back of strong revenue growth...

11 Apr 2011

Cannabis-based medicines group GW Pharmaceuticals (GW) could receive over $30m under a new licence agreement with pharmaceutical giant Novartis Pharma...

8 Dec 2010

Solomon Trujillo, a recently-appointed director at the advertising group WPP, has splashed out about £76,000 shares in the firm. He took 2,000 Ameri...

23 Nov 2010

Shares in Intellego jumped after the training consultancy group said it had made a good start with its trial programme providing financial services pr...

3 Nov 2010

Cannabis based medicines group GW Pharmaceuticals has had its Sativex treatment for the relief of spasticity in Multiple Sclerosis (MS) approved by th...